Biochemical and Structural Characterization of SplD Protease from Staphylococcus aureus

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Zdzalik, Michal ^a   Kalinska, Magdalena ^a   Wysocka, Magdalena ^b   Stec Niemczyk, Justyna ^a   Cichon, Przemyslaw ^a   Stach, Natalia ^a   Gruba, Natalia ^b   Stennicke, Henning R ^c   Jabaiah, Abeer ^d   Markiewicz, Michal ^a   Kedracka Krok, Sylwia ^a   Wladyka, Benedykt ^a   Daugherty, Patrick S ^d   Lesner, Adam ^b   Rolka, Krzysztof ^b   Dubin, Adam ^a   Potempa, Jan ^a,e   Dubin, Grzegorz ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY OF GDA SK   (Poland)

^c NOVO NORDISK A S   (Denmark)

^d University of California   (United States)

^e UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; BACTERIAL ENZYME; ISOLEUCINE; LEUCINE; SERINE; SPLD PROTEASE; THREONINE; UNCLASSIFIED DRUG; VALINE;

ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ANALYSIS; ENZYME MECHANISM; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; ESCHERICHIA COLI; HIGH THROUGHPUT SEQUENCING; MOLECULAR MODEL; NONHUMAN; SITE DIRECTED MUTAGENESIS; STAPHYLOCOCCUS AUREUS; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

CATALYTIC DOMAIN; HUMANS; MODELS, MOLECULAR; MUTAGENESIS; PEPTIDE HYDROLASES; PEPTIDES; PROTEOLYSIS; STAPHYLOCOCCUS AUREUS; SUBSTRATE SPECIFICITY;

EID: 84885086534     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076812     Document Type: Article

References (66)

1. van Belkum A, Verkaik NJ, de Vogel CP, Boelens HA, Verveer J, et al. (2009) Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis 199: 1820-1826. doi:10.1086/599119. PubMed: 19419332.
2. Peacock SJ, de Silva I, Lowy FD, (2001) What determines nasal carriage of Staphylococcus aureus? Trends Microbiol 9: 605-610. doi:10.1016/S0966-842X(01)02254-5. PubMed: 11728874.
3. Foster T, (1996) Staphylococcus. In: Baron S, eds. Medical Microbiology. 4th ed. Galveston (TX).
4. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, et al. (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298: 1763-1771. doi:10.1001/jama.298.15.1763. PubMed: 17940231.
5. Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, et al. (2006) Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 42: 389-391. doi:10.1086/499367. PubMed: 16392087.
6. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, et al. (2001) Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 32 (Suppl 2):: S114-S132. doi:10.1086/320184. PubMed: 11320452.
7. Abdelnour A, Arvidson S, Bremell T, Rydén C, Tarkowski A, (1993) The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun 61: 3879-3885. PubMed: 8359909.
8. Shaw L, Golonka E, Potempa J, Foster SJ, (2004) The role and regulation of the extracellular proteases of Staphylococcus aureus. Microbiology 150: 217-228. doi:10.1099/mic.0.26634-0. PubMed: 14702415.
9. Potempa J, Watorek W, Travis J, (1986) The inactivation of human plasma alpha 1-proteinase inhibitor by proteinases from Staphylococcus aureus. J Biol Chem 261: 14330-14334. PubMed: 3533918.
10. Maeda H, Yamamoto T, (1996) Pathogenic mechanisms induced by microbial proteases in microbial infections. Biol Chem Hoppe Seyler 377: 217-226. doi:10.1515/bchm3.1996.377.4.217. PubMed: 8737987.
11. Arvidson J, Lönnerholm G, Tuvemo T, Carlson K, Lannering B, et al. (2000) Prepubertal growth and growth hormone secretion in children after treatment for hematological malignancies, including autologous bone marrow transplantation. Pediatr Hematol Oncol 17: 285-297. doi:10.1080/088800100276271. PubMed: 10845227.
12. McAleese FM, Walsh EJ, Sieprawska M, Potempa J, Foster TJ, (2001) Loss of clumping factor B fibrinogen binding activity by Staphylococcus aureus involves cessation of transcription, shedding and cleavage by metalloprotease. J Biol Chem 276: 29969-29978. doi:10.1074/jbc.M102389200. PubMed: 11399757.
13. Sieprawska-Lupa M, Mydel P, Krawczyk K, Wójcik K, Puklo M, et al. (2004) Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48: 4673-4679. doi:10.1128/AAC.48.12.4673-4679.2004. PubMed: 15561843.
14. Rudack C, Sachse F, Albert N, Becker K, von Eiff C, (2009) Immunomodulation of nasal epithelial cells by Staphylococcus aureus-derived serine proteases. J Immunol 183: 7592-7601. doi:10.4049/jimmunol.0803902. PubMed: 19917683.
15. Dubin G, Koziel J, Pyrc K, Wladyka B, Potempa J, (2012) Bacterial proteases in disease- role in intracellular survival, evasion of coagulation/fibrinolysis innate defenses, toxicoses and viral infections. Curr Pharm Des.
16. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, et al. (2001) Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357: 1225-1240. doi:10.1016/S0140-6736(00)04403-2. PubMed: 11418146.
17. Zdzalik M, Karim AY, Wolski K, Buda P, Wojcik K, et al. (2012) Prevalence of genes encoding extracellular proteases in Staphylococcus aureus- important targets triggering immune response in vivo. FEMS Immunol Med Microbiol 66: 220-229. doi:10.1111/j.1574-695X.2012.01005.x. PubMed: 22762789.
18. Reed SB, Wesson CA, Liou LE, Trumble WR, Schlievert PM, et al. (2001) Molecular characterization of a novel Staphylococcus aureus serine protease operon. Infect Immun 69: 1521-1527. doi:10.1128/IAI.69.3.1521-1527.2001. PubMed: 11179322.
19. Ziebandt AK, Becher D, Ohlsen K, Hacker J, Hecker M, et al. (2004) The influence of agr and sigmaB in growth phase dependent regulation of virulence factors in Staphylococcus aureus. Proteomics 4: 3034-3047. doi:10.1002/pmic.200400937. PubMed: 15378746.
20. Rieneck K, Renneberg J, Diamant M, Gutschik E, Bendtzen K, (1997) Molecular cloning and expression of a novel Staphylococcus aureus antigen. Biochim Biophys Acta 1350: 128-132. doi:10.1016/S0167-4781(96)00216-3. PubMed: 9048880.
21. Popowicz GM, Dubin G, Stec-Niemczyk J, Czarny A, Dubin A, et al. (2006) Functional and structural characterization of Spl proteases from Staphylococcus aureus. J Mol Biol 358: 270-279. doi:10.1016/j.jmb.2006.01.098. PubMed: 16516230.
22. Dubin G, Stec-Niemczyk J, Kisielewska M, Pustelny K, Popowicz GM, et al. (2008) Enzymatic activity of the Staphylococcus aureus SplB serine protease is induced by substrates containing the sequence Trp-Glu-Leu-Gln. J Mol Biol 379: 343-356. doi:10.1016/j.jmb.2008.03.059. PubMed: 18448121.
23. Stec-Niemczyk J, Pustelny K, Kisielewska M, Bista M, Boulware KT, et al. (2009) Structural and functional characterization of SplA, an exclusively specific protease of Staphylococcus aureus. Biochem J 419: 555-564. doi:10.1042/BJ20081351. PubMed: 19175361.
24. Berthold H, Frorath B, Scanarini M, Abney CC, Ernst B, et al. (1992) Plasmid pGEX-5T: An alternative system for expression and purification of recombinant proteins. Biotechnol Lett 14: 245-250. doi:10.1007/BF01022318.
25. Arvidson S, Holme T, Lindholm B, (1973) Studies on extracellular proteolytic enzymes from Staphylococcus aureus. I. Purification and characterization of one neutral and one alkaline protease. Biochim Biophys Acta 302: 135-148. doi:10.1016/0005-2744(73)90016-8. PubMed: 4632562.
26. Snipas SJ, Wildfang E, Nazif T, Christensen L, Boatright KM, et al. (2004) Characteristics of the caspase-like catalytic domain of human paracaspase. Biol Chem 385: 1093-1098. PubMed: 15576331.
27. Houghten RA, Pinilla C, Blondelle SE, Appel JR, Dooley CT, et al. (1991) Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature 354: 84-86. doi:10.1038/354084a0. PubMed: 1719428.
28. Wysocka M, Kwiatkowska B, Rzadkiewicz M, Lesner A, Rolka K, (2007) Selection of new chromogenic substrates of serine proteinases using combinatorial chemistry methods. Comb Chem High Throughput Screen 10: 171-180. doi:10.2174/138620707780126714. PubMed: 17346116.
29. Kalinska M, Kantyka T, Greenbaum DC, Larsen KS, Wladyka B, et al. (2012) Substrate specificity of Staphylococcus aureus cysteine proteases--Staphopains A, B and C. Biochimie 94: 318-327.
30. Lesner A, Brzozowski K, Kupryszewski G, Rolka K, (2000) Design, chemical synthesis and kinetic studies of trypsin chromogenic substrates based on the proteinase binding loop of Cucurbita maxima trypsin inhibitor (CMTI-III). Biochem Biophys Res Commun 269: 81-84. doi:10.1006/bbrc.2000.2257. PubMed: 10694481.
31. Lesner A, Kupryszewski G, Rolka K, (2001) Chromogenic substrates of bovine beta-trypsin: the influence of an amino acid residue in P1 position on their interaction with the enzyme. Biochem Biophys Res Commun 285: 1350-1353. doi:10.1006/bbrc.2001.5339. PubMed: 11478806.
32. Boulware KT, Daugherty PS, (2006) Protease specificity determination by using cellular libraries of peptide substrates (CLiPS). Proc Natl Acad Sci U S A 103: 7583-7588. doi:10.1073/pnas.0511108103. PubMed: 16672368.
33. Leslie AGW, (1992) Recent changes to MOSFLM package for processing film and image image plate data. Joint CCP4 and ESF-EAMCB. Newsletter on Protein Crystallography 6.
34. Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, et al. (2011) Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 67: 235-242. doi:10.1107/S0907444910045749. PubMed: 21460441.
35. Evans P, (2006) Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr 62: 72-82. doi:10.1107/S0108767306098564. PubMed: 16369096.
36. Evans PR, (1997) Scala. Joint CCP4 and ESF-EAMCB. Newsletter 33: 22-24.
37. McCoy AJ, Grosse-Kunstleve RW, Storoni LC, Read RJ, (2005) Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr 61: 458-464. doi:10.1107/S0108767305080840. PubMed: 15805601.
38. Emsley P, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126-2132. doi:10.1107/S0907444904019158. PubMed: 15572765.
39. Vagin AA, Steiner RA, Lebedev AA, Potterton L, McNicholas S, et al. (2004) REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use. Acta Crystallogr D Biol Crystallogr 60: 2184-2195. doi:10.1107/S0907444904023510. PubMed: 15572771.
40. Brünger AT, (1992) Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355: 472-475. doi:10.1038/355472a0. PubMed: 18481394.
41. Lamzin VS, Wilson KS, (1993) Automated refinement of protein models. Acta Crystallogr D Biol Crystallogr 49: 129-147. doi:10.1107/S0108767378096270. PubMed: 15299554.
42. Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E, et al. (2012) Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. J Cheminform 4: 17. doi:10.1186/1758-2946-4-17. PubMed: 22889332.
43. Avogadro, (2012) Avogadro: an open-source molecular builder and visualization tool. Version 1.0.3.
44. Krowarsch D, Cierpicki T, Jelen F, Otlewski J, (2003) Canonical protein inhibitors of serine proteases. Cell Mol Life Sci 60: 2427-2444. doi:10.1007/s00018-003-3120-x. PubMed: 14625687.
45. Perona JJ, Craik CS, (1995) Structural basis of substrate specificity in the serine proteases. Protein Sci 4: 337-360. PubMed: 7795518.
46. Hedstrom L, (2002) Serine protease mechanism and specificity. Chem Rev 102: 4501-4524. doi:10.1021/cr000033x. PubMed: 12475199.
47. MacKerell AD Jr, Brooks B, Brooks CL III, Nilsson L, Roux B, et al. (1998) CHARMM: the energy function and its parameterization. Encyclopedia of computational chemistry.
48. Mackerell AD Jr, (2004) Empirical force fields for biological macromolecules: overview and issues. J Comput Chem 25: 1584-1604. doi:10.1002/jcc.20082. PubMed: 15264253.
49. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML, (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79: 926-935. doi:10.1063/1.445869.
50. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, et al. (1995) A smooth particle mesh ewald method. J Chem Phys 103: 8577-8593. doi:10.1063/1.470117.
51. Parrinello M, Rahman A, (1981) Polymorphic transitions in single crystals: A new molecular dynamics method. J Appl Phys 52: 7182-7190. doi:10.1063/1.328693.
52. Bussi G, Donadio D, Parrinello M, (2007) Canonical sampling through velocity rescaling. J Chem Phys 126: 014101. doi:10.1063/1.2408420. PubMed: 17212484.
53. Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, et al. (2005) GROMACS: fast, flexible, and free. J Comput Chem 26: 1701-1718. doi:10.1002/jcc.20291. PubMed: 16211538.
54. Hess B, Kutzner C, van der Spoel D, Lindahl E, (2008) GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J Chem Theory Comput 4: 435-447.
55. Schechter I, Berger A, (1967) On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 27: 157-162. doi:10.1016/S0006-291X(67)80055-X. PubMed: 6035483.
56. Lesk AM, Fordham WD, (1996) Conservation and variability in the structures of serine proteinases of the chymotrypsin family. J Mol Biol 258: 501-537. doi:10.1006/jmbi.1996.0264. PubMed: 8642605.
57. Perona JJ, Craik CS, (1997) Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold. J Biol Chem 272: 29987-29990. doi:10.1074/jbc.272.48.29987. PubMed: 9374470.
58. Page MJ, Di Cera E, (2008) Serine peptidases: classification, structure and function. Cell Mol Life Sci 65: 1220-1236. doi:10.1007/s00018-008-7565-9. PubMed: 18259688.
59. Freer ST, Kraut J, Robertus JD, Wright HT, Xuong NH, (1970) Chymotrypsinogen: 2.5-angstrom crystal structure, comparison with alpha-chymotrypsin, and implications for zymogen activation. Biochemistry 9: 1997-2009. doi:10.1021/bi00811a022. PubMed: 5442169.
60. Stroud RM, Kossiakoff AA, Chambers JL, (1977) Mechanisms of zymogen activation. Annu Rev Biophys Bioeng 6: 177-193. doi:10.1146/annurev.bb.06.060177.001141. PubMed: 17350.
61. Rawlings ND, Barrett AJ, Bateman A, (2010) MEROPS: the peptidase database. Nucleic Acids Res 38: D227-D233. doi:10.1093/nar/gkp971. PubMed: 19892822.
62. Doucet A, Overall CM, (2011) Broad coverage identification of multiple proteolytic cleavage site sequences in complex high molecular weight proteins using quantitative proteomics as a complement to edman sequencing. Mol Cell Proteomics 10: 003533 20876890.
63. Schilling O, Overall CM, (2008) Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites. Nat Biotechnol 26: 685-694. doi:10.1038/nbt1408. PubMed: 18500335.
64. Bateman KS, Anderson S, Lu W, Qasim MA, Laskowski M Jr., et al. (2000) Deleterious effects of beta-branched residues in the S1 specificity pocket of Streptomyces griseus proteinase B (SGPB): crystal structures of the turkey ovomucoid third domain variants Ile18I, Val18I, Thr18I, and Ser18I in complex with SGPB. Protein Sci 9: 83-94. PubMed: 10739250.
65. Sauter NK, Mau T, Rader SD, Agard DA, (1998) Structure of alpha-lytic protease complexed with its pro region. Nat Struct Biol 5: 945-950. doi:10.1038/2919. PubMed: 9808037.
66. Biedermannova L, E Riley K, Berka K, Hobza P, Vondrasek J, (2008) Another role of proline: stabilization interactions in proteins and protein complexes concerning proline and tryptophane. Phys Chem Chem Phys 10: 6350-6359. doi:10.1039/b805087b. PubMed: 18972023.